Search Results - Alan Talevi
- Showing 1 - 14 results of 14
-
1
-
2
-
3
-
4
Cannabidiol combined with GABAergic drugs but not with sodium channel blockers prevents the development of drug-resistance seizures in a preclinical model by Monserrat Fuentes-Mejia, Maximiliano J. Fallico, Alan Talevi, Luciana Gavernet, Sandra A. Orozco-Suárez, Luisa Rocha
Published in Frontiers in Pharmacology (2025-09-01)Get full text
Article -
5
LIDEB's Useful Decoys (LUDe): A freely available decoy-generation tool. Benchmarking and scope by Lucas N. Alberca, Denis N. Prada Gori, Maximiliano J. Fallico, Alexandre V. Fassio, Alan Talevi, Carolina L. Bellera
Published in Artificial Intelligence in the Life Sciences (2025-06-01)Get full text
Article -
6
Potential biocide roles of violacein by Ignacio Rivero Berti, Melisa E. Gantner, Santiago Rodriguez, German A. Islan, Wagner J. Fávaro, Alan Talevi, Guillermo R. Castro, Nelson Durán, Nelson Durán
Published in Frontiers in Nanotechnology (2023-07-01)Get full text
Article -
7
Crystal Structure of Melphalan Hydrochloride and Its Association with Caffeine Improves Its Antineoplastic Action by Juliana Pereira da Silva, Carin Cristina da Silva Batista, Maria Lúcia Schumacher, Santiago Rodriguez, Alan Talevi, Paula Haddad, Guillermo Raul Castro, Fabio Furlan Ferreira
Published in ACS Omega (2025-05-01)Get full text
Article -
8
In Silico Screening Identification of Fatty Acids and Fatty Acid Derivatives with Antiseizure Activity: In Vitro and In Vivo Validation by Emilia Mercedes Barrionuevo, Estefanía Peralta, Agustín Manzur De Nardi, Juliana Monat, Maximiliano José Fallico, Manuel Augusto Llanos, Luciana Gavernet, Emilio Román Mustafá, Pedro Martin, Alan Talevi
Published in Pharmaceutics (2024-07-01)Get full text
Article -
9
A structure-based approach towards the identification of novel antichagasic compounds: Trypanosoma cruzi carbonic anhydrase inhibitors by Manuel A. Llanos, María L. Sbaraglini, María L. Villalba, María D. Ruiz, Carolina Carrillo, Catalina Alba Soto, Alan Talevi, Andrea Angeli, Seppo Parkkila, Claudiu T. Supuran, Luciana Gavernet
Published in Journal of Enzyme Inhibition and Medicinal Chemistry (2020-01-01)Get full text
Article -
10
Machine Learning in Drug Discovery and Development Part 1: A Primer by Alan Talevi, Juan Francisco Morales, Gregory Hather, Jagdeep T. Podichetty, Sarah Kim, Peter C. Bloomingdale, Samuel Kim, Jackson Burton, Joshua D. Brown, Almut G. Winterstein, Stephan Schmidt, Jensen Kael White, Daniela J. Conrado
Published in CPT: Pharmacometrics & Systems Pharmacology (2020-03-01)Get full text
Article -
11
Cascade Ligand- and Structure-Based Virtual Screening to Identify New Trypanocidal Compounds Inhibiting Putrescine Uptake by Lucas N. Alberca, María L. Sbaraglini, Juan F. Morales, Roque Dietrich, María D. Ruiz, Agustina M. Pino Martínez, Cristian G. Miranda, Laura Fraccaroli, Catalina D. Alba Soto, Carolina Carrillo, Pablo H. Palestro, Alan Talevi
Published in Frontiers in Cellular and Infection Microbiology (2018-05-01)Get full text
Article -
12
Drug repurposing screening validated by experimental assays identifies two clinical drugs targeting SARS-CoV-2 main protease by Denis N. Prada Gori, Santiago Ruatta, Santiago Ruatta, Martín Fló, Martín Fló, Lucas N. Alberca, Carolina L. Bellera, Soonju Park, Jinyeong Heo, Honggun Lee, Kyu-Ho Paul Park, Otto Pritsch, Otto Pritsch, David Shum, Marcelo A. Comini, Alan Talevi
Published in Frontiers in Drug Discovery (2023-01-01)Get full text
Article -
13
Nanostructured lipid carriers containing benznidazole: physicochemical, biopharmaceutical and cellular in vitro studies by Giuliana Muraca, María Esperanza Ruiz, Rocío C. Gambaro, Sebastián Scioli-Montoto, María Laura Sbaraglini, Gisel Padula, José Sebastián Cisneros, Cecilia Yamil Chain, Vera A. Álvarez, Cristián Huck-Iriart, Guillermo R. Castro, María Belén Piñero, Matias Ildebrando Marchetto, Catalina Alba Soto, Germán A. Islan, Alan Talevi
Published in Beilstein Journal of Nanotechnology (2023-07-01)Get full text
Article -
14
Garbage in, garbage out: how reliable training data improved a virtual screening approach against SARS-CoV-2 MPro by Santiago M. Ruatta, Santiago M. Ruatta, Denis N. Prada Gori, Martín Fló Díaz, Martín Fló Díaz, Franca Lorenzelli, Karen Perelmuter, Lucas N. Alberca, Lucas N. Alberca, Carolina L. Bellera, Carolina L. Bellera, Andrea Medeiros, Andrea Medeiros, Gloria V. López, Gloria V. López, Mariana Ingold, Williams Porcal, Williams Porcal, Estefanía Dibello, Irina Ihnatenko, Conrad Kunick, Marcelo Incerti, Martín Luzardo, Maximiliano Colobbio, Maximiliano Colobbio, Juan Carlos Ramos, Juan Carlos Ramos, Eduardo Manta, Eduardo Manta, Lucía Minini, María Laura Lavaggi, Paola Hernández, Jonas Šarlauskas, César Sebastian Huerta García, Rafael Castillo, Alicia Hernández-Campos, Giovanni Ribaudo, Giuseppe Zagotto, Renzo Carlucci, Noelia S. Medrán, Guillermo R. Labadie, Maitena Martinez-Amezaga, Carina M. L. Delpiccolo, Ernesto G. Mata, Laura Scarone, Laura Posada, Gloria Serra, Theodora Calogeropoulou, Kyriakos Prousis, Anastasia Detsi, Mauricio Cabrera, Guzmán Alvarez, Adrián Aicardo, Adrián Aicardo, Adrián Aicardo, Verena Araújo, Verena Araújo, Verena Araújo, Cecilia Chavarría, Cecilia Chavarría, Lucija Peterlin Mašič, Melisa E. Gantner, Melisa E. Gantner, Manuel A. Llanos, Manuel A. Llanos, Santiago Rodríguez, Luciana Gavernet, Luciana Gavernet, Soonju Park, Jinyeong Heo, Honggun Lee, Kyu-Ho Paul Park, Mariela Bollati-Fogolín, Otto Pritsch, Otto Pritsch, David Shum, Alan Talevi, Alan Talevi, Marcelo A. Comini
Published in Frontiers in Pharmacology (2023-06-01)Get full text
Article